Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:telmisartan
|
| gptkbp:approvalYear |
1998
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
C09CA07
|
| gptkbp:bioavailability |
42-58%
|
| gptkbp:contraindication |
pregnancy
hypersensitivity to telmisartan |
| gptkbp:drugClass |
angiotensin II receptor blocker
|
| gptkbp:eliminatedIn |
biliary excretion
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:halfLife |
24 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Micardis
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Boehringer_Ingelheim
|
| gptkbp:pregnancyCategory |
D
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:sinusitis
dizziness back pain |
| gptkbp:usedFor |
hypertension
cardiovascular risk reduction |
| gptkbp:bfsParent |
gptkb:Boehringer_Ingelheim_Group
|
| gptkbp:bfsLayer |
7
|